BridgeMD
New treatment option for Subacute Delirium
Official title Nutritional Therapy for Delirium in Elderly Hospitalized Subjects
ClinicalTrials.gov ID: NCT05066503
What this study is testing
- What it's testing
- The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older adults (60 years and older) who are hospitalized for certain infections. In this study, up to 60 people will be enrolled.20 will be asked to drink this blend twice a day for up to 4 days, and 20 will receive standard treatment in the hospital for the same time period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Delirious cohort
- Aged 60 years and older.
- Documented presence of either delirium, acute confusion, or altered mental status in medical record.
- Currently hospitalized with a diagnosis of one of the following:
- sepsis/septicemia
You likely can't join if
- all people
- Chronic kidney disease (eGFR \<30).
- Admitted to the hospital for major psychiatric illness.
- Major psychiatric illness not controlled by medication/treatment.
- Delirium etiology of drug overdose or alcohol withdrawal.
- Major surgery within the past five days.
See the full eligibility criteria
- Delirious cohort
- Aged 60 years and older.
- Documented presence of either delirium, acute confusion, or altered mental status in medical record.
- Currently hospitalized with a diagnosis of one of the following:
- sepsis/septicemia
- Pneumonia
- Urinary tract infection
- Clostridium-difficile infection
- Other bone or tissue infection
- Fever of unknown origin NON-Delirious cohort
- Aged 60 years and older.
- Current diagnosis of one of the following:
- sepsis/septicemia
- Pneumonia
- Urinary tract infection
- Clostridium-difficile infection
- Other bone or tissue infection
- Fever of unknown origin
- all people
- Chronic kidney disease (eGFR \<30).
- Admitted to the hospital for major psychiatric illness.
- Major psychiatric illness not controlled by medication/treatment.
- Delirium etiology of drug overdose or alcohol withdrawal.
- Major surgery within the past five days.
- Known or suspected Covid-19 positive.
- Continuous feeding tube
The study team makes the final eligibility decision.
Where it's taking place
- Little Rock, Arkansas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Little Rock, Arkansas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.